By improving metabolic function, GLP-1RAs may not only enhance disease control but also optimize responses to concomitant therapies during the critical early phases of PsA
Your provider will track your response and make program adjustments as needed over time
Unlike Ozempic and Wegovy, which undergo rigorous clinical testing, compounded versions may vary between batches, leading to potential risks
For example, if a patient has trouble swallowing pills, the compounding pharmacy can create a compounded semaglutide that is administered as a liquid or a nasal spray
Poor sleep can affect blood sugar regulation and appetite, making it harder to manage diabetes and weight
As semaglutide reduces weight, this risk should theoretically decrease, but the transition period, where rapid weight loss causes fluid shifts and muscle wasting, may temporarily increase risk before the long-term protective effects kick in